7LGI image
Entry Detail
PDB ID:
7LGI
Keywords:
Title:
The haddock model of GDP KRas in complex with promazine using chemical shift perturbations and intermolecular NOEs
Biological Source:
Source Organism:
Host Organism:
PDB Version:
Deposition Date:
2021-01-20
Release Date:
2021-07-21
Method Details:
Experimental Method:
Conformers Calculated:
1000
Conformers Submitted:
10
Selection Criteria:
structures with the lowest energy
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:GTPase KRas
Chain IDs:A
Chain Length:169
Number of Molecules:1
Biological Source:Homo sapiens
Primary Citation
Antipsychotic phenothiazine drugs bind to KRAS in vitro.
J.Biomol.Nmr 75 233 244 (2021)
PMID: 34176062 DOI: 10.1007/s10858-021-00371-z

Abstact

We used NMR to show that the antipsychotic phenothiazine drugs promazine and promethazine bind to GDP-KRAS. Promazine also binds to oncogenic GDP-KRAS(G12D), and to wild type GppNHp-KRAS. A panel of additional phenothiazines bind to GDP-KRAS but with lower affinity than promazine or promethazine. Binding is most dependent on substitutions at C-2 of the tricyclic phenothiazine ring. Promazine was used to generate an NMR-driven HADDOCK model of the drug/GDP-KRAS complex. The structural model shows the tricyclic phenothiazine ring of promazine associates with the hydrophobic pocket p1 that is bordered by the central β sheet and Switch II in KRAS. Binding appears to stabilize helix 2 in a conformation that is similar to that seen in KRAS bound to other small molecules. Association of phenothiazines with KRAS may affect normal KRAS signaling that could contribute to multiple biological activities of these antipsychotic drugs. Moreover, the phenothiazine ring represents a new core scaffold on which to design modulators of KRAS activity.

Legend

Protein

Chemical

Disease

Primary Citation of related structures